Previous Close | 15.50 |
Open | 17.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 16.35 - 17.00 |
52 Week Range | 8.95 - 17.60 |
Volume | 124,612 |
Avg. Volume | 110,295 |
Market Cap | 692.5M |
Beta | 1.55 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.05 |
Earnings Date | May 2, 2018 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 19.00 |
MONROVIA, Calif. , April 18, 2018 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, ...
Glancy Prongay & Murray LLP announces an investigation on behalf of STAAR Surgical Company investors concerning the Company and its directors’ and officers’ possible violations of state laws.
Q4 2017 STAAR Surgical Co Earnings Call
NEW YORK, March 01, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
The Monrovia, California-based company said it had a loss of less than 1 cent on a per-share basis. Earnings, adjusted for non-recurring costs, were 2 cents per share. The maker of implantable lenses posted ...
MONROVIA, Calif. , Feb. 28, 2018 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, ...
NEW YORK, NY / ACCESSWIRE / February 28, 2018 / STAAR Surgical Company (NASDAQ: STAA ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 28, 2018, at 4:30 PM Eastern ...
Measuring STAAR Surgical Company’s (NASDAQ:STAA) track record of past performance is an insightful exercise for investors. It enables us to reflect on whether the company has met or exceed expectations,Read More...
MONROVIA, Calif. , Feb. 14, 2018 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, ...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to STAAR Surgical Co. Here are 5 ETFs with the largest exposure to STAA-US. Comparing the performance and risk of STAAR Surgical Co. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
MONROVIA, Calif., Nov. 15, 2017 /PRNewswire/ -- STAAR Surgical Company (STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will provide a webcast of President & CEO Caren Mason's presentation during its upcoming Investor and Analyst Day. STAAR Surgical will host an Investor and Analyst Day on Thursday, November 16, 2017 at the STAAR Surgical R&D Center. The Company will also provide a webcast beginning at 11 a.m. ET.
Q3 2017 STAAR Surgical Co Earnings Call
The Monrovia, California-based company said it had net income of 3 cents per share. Earnings, adjusted for one-time gains and costs, came to 4 cents per share. The maker of implantable lenses posted revenue ...
MONROVIA, Calif. , Nov. 8, 2017 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye today ...
NEW YORK, NY / ACCESSWIRE / November 8, 2017 / STAAR Surgical Company (NASDAQ: STAA ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 8, 2017 at 4:30 PM Eastern ...
MONROVIA, Calif. , Oct. 25, 2017 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, ...
Distinguished Ophthalmology Clinician to Serve as Strategic Guide for STAAR's Medical & Professional Affairs as well as Product Development Pathways MONROVIA, Calif. , Oct. 2, 2017 /PRNewswire/ -- STAAR ...
Surindra Mann Joins STAAR as Vice President, Global Financial Planning & Analysis MONROVIA, Calif. , Sept. 28, 2017 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer ...
AbbVie downgraded to Neutral, and Quest Diagnostics reduced to Market Perform
STAAR Surgical Company (STAA) was a big mover last session, as the company saw its shares rise over 9% on the day.
The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew
Categories: Yahoo FinanceGet free summary analysis STAAR Surgical Co. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of STAAR Surgical Co. – Cooper Companies, Inc., TearLab Corp., Atrion Corporation, IRIDEX Corporation and Valeant Pharmaceuticals International Inc (COO-US, TEAR-US, ATRI-US, IRIX-US and VRX-US) that have also reported ... Read more (Read more...)